United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Auto and Transport Industry News How Exicom’s Q4 FY25 recovery signals a strategic shift in EV and critical power markets Exicom returns to profit in Q4 FY25 with EV and telecom gains. Discover how its Tritium push and Harmony 2.0 launch could power future growth. byPallavi MadhirajuMay 24, 2025